Dr. Sandip Kapur, Chief of Transplant Surgery at NewYork-Presbyterian/Weill Cornell and a Leading Authority on Transplantation, Is Available for Expert Commentary
Newswise — NEW YORK (April 29, 2011) -- Available for expert commentary on the latest research findings presented at the 2011 American Transplant Congress (ATC) in Philadelphia, April 30 to May 4, is Dr. Sandip Kapur, chief of transplant surgery and director of kidney and pancreas transplant programs at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, and a leading authority on transplantation.
The following are some notable research studies by Dr. Kapur and colleagues being presented at the meeting:
* Excellent Outcomes Shown for Pancreas Transplantation in Older Patients
Due to improvements in the management of diabetes, there are an increasing number of older candidates for pancreas transplantation. Recent studies have been equivocal about outcomes for older patients, but, on the positive side, none have shown an increase in acute rejection or complication rates. In their retrospective review, Dr. Kapur and his co-investigators found that pancreas transplantation in older patients is safe and feasible, with excellent graft and patient outcomes. They report that with proper patient selection, older patients can safely receive a pancreas transplant without an increased risk of complications, infections requiring hospitalization, or cytomegalovirus (CMV) infections. Furthermore, these patients also benefit from a lower rejection rate over the lifespan of the transplant.
Concurrent Session 19: Pancreas Transplantation: Clinical Management and Complications. Sunday, May 1, 2011, 4:12 p.m. Room 113 B.
* Excellent Outcomes for Pancreas Transplantation in Underweight and Obese Patients
Pancreas transplantation remains an important option for patients with Type 1 diabetes. Given the metabolic problems associated with diabetes, pancreas transplant candidates may struggle to maintain a healthy body mass index (BMI). As a result, extreme BMIs are sometimes encountered with this condition. Dr. Kapur and his co-investigators report their experience of pancreas transplantation outcomes according to BMI categories. They found that underweight and obese patients have excellent outcomes after pancreas transplantation. With careful selection, these patients should not have an increased risk of postoperative or infectious complications. Furthermore, extremes of BMI do not limit transplant success or patient survival.
Poster Session: Pancreas Transplant: All Topics. Monday, May 2, 2011, 5:30 p.m. Hall B.
* Improved Recovery for Kidney Donors Undergoing Laparoendoscopic Single-Site Donor Nephrectomy (LESS-DN) Compared With Laparoscopic Donor Nephrectomy (LDN)
Laparoscopic donor nephrectomy (LDN) has become the standard of care for kidney retrieval at high-volume transplant centers. Recently, laparoendoscopic single-site donor nephrectomy (LESS-DN) has emerged with the potential benefits of improved cosmesis and convalescence, and decreased morbidity. In the LESS-DN procedure, a natural orifice (the umbilicus or belly button) is used as the single incision site through which the entire donor nephrectomy is performed. Dr. Kapur, along with NewYork-Presbyterian/Weill Cornell surgeon Dr. Joseph Del Pizzo and their co-investigators, describe their experience with 100 consecutive patients undergoing LESS-DN. They report that patients undergoing LESS-DN benefitted from improved donor recovery outcomes and smaller incisions compared with LDN, despite longer operative times.
Concurrent Session 49: Surgical and Utilization Issues. Monday, May 2, 2011, 4 p.m. Room 108 AB.
Organ Transplantation at NewYork-Presbyterian HospitalThe organ transplantation program at NewYork-Presbyterian Hospital -- which includes NewYork-Presbyterian Hospital/Weill Cornell, NewYork-Presbyterian Hospital/Columbia and The Rogosin Institute -- is the most active program of its kind in the nation, offering comprehensive and personalized care for the heart, liver, pancreas, kidney and lung. With outcomes ranked among the nation's best, the Hospital is dedicated to improving quality of life for its patients. NewYork-Presbyterian's dedicated teams of surgeons and physicians are responsible for many significant advances made over the past several decades in transplant surgery and the maintenance of healthy organs. The Hospital has been on the forefront of developing and improving anti-rejection medications (immunosuppressants), minimally invasive surgery for living donors, genetic methods to detect transplant rejection, strategies to increase opportunities for donor matching, islet cell transplantation, and the FDA-approved Left Ventricle Assist Device (LVAD) that functions as a bridge to transplantation for those waiting for a new heart.
NewYork-Presbyterian Hospital/Weill Cornell Medical CenterNewYork-Presbyterian Hospital/Weill Cornell Medical Center, located in New York City, is one of the leading academic medical centers in the world, comprising the teaching hospital NewYork-Presbyterian and Weill Cornell Medical College, the medical school of Cornell University. NewYork-Presbyterian/Weill Cornell provides state-of-the-art inpatient, ambulatory and preventive care in all areas of medicine, and is committed to excellence in patient care, education, research and community service. Weill Cornell physician-scientists have been responsible for many medical advances -- including the development of the Pap test for cervical cancer; the synthesis of penicillin; the first successful embryo-biopsy pregnancy and birth in the U.S.; the first clinical trial for gene therapy for Parkinson's disease; the first indication of bone marrow's critical role in tumor growth; and, most recently, the world's first successful use of deep brain stimulation to treat a minimally conscious brain-injured patient. NewYork-Presbyterian Hospital also comprises NewYork-Presbyterian Hospital/Columbia University Medical Center, NewYork-Presbyterian/Morgan Stanley Children's Hospital, NewYork-Presbyterian Hospital/Westchester Division and NewYork-Presbyterian/The Allen Hospital. NewYork-Presbyterian is the #1 hospital in the New York metropolitan area and is consistently ranked among the best academic medical institutions in the nation, according to U.S.News & World Report. Weill Cornell Medical College is the first U.S. medical college to offer a medical degree overseas and maintains a strong global presence in Austria, Brazil, Haiti, Tanzania, Turkey and Qatar. For more information, visit www.nyp.org and weill.cornell.edu.
RSS